Cargando…

Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD

BACKGROUND: Although use of complementary and alternative medicine (CAM) among cancer patients has been described previously, prevalence of use has not commonly been compared to other disease groups in a true population sample where CAM use or cancer is not the main focus. The aims of the present st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristoffersen, Agnete E, Norheim, Arne J, Fønnebø, Vinjar M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305410/
https://www.ncbi.nlm.nih.gov/pubmed/22240073
http://dx.doi.org/10.1186/1472-6882-12-1
_version_ 1782227063824973824
author Kristoffersen, Agnete E
Norheim, Arne J
Fønnebø, Vinjar M
author_facet Kristoffersen, Agnete E
Norheim, Arne J
Fønnebø, Vinjar M
author_sort Kristoffersen, Agnete E
collection PubMed
description BACKGROUND: Although use of complementary and alternative medicine (CAM) among cancer patients has been described previously, prevalence of use has not commonly been compared to other disease groups in a true population sample where CAM use or cancer is not the main focus. The aims of the present study are to (1) examine how CAM use in cancer patients differs from people with a previous CHD diagnosis and people with no cancer or CHD diagnosis in an unselected general population and (2), investigate the use of a CAM provider among individuals with a previous cancer diagnosis. METHODS: A total of 8040 men and women aged 29 to 87 in the city of Tromsø, Norway filled in a questionnaire developed specifically for the Tromsø V study with questions on life style and health issues. Visits to a CAM provider within the last 12 months and information on cancer, heart attack and angina pectoris (heart cramp) were among the questions. 1449 respondents were excluded from the analyses. RESULTS: Among the 6591 analysed respondents 331 had a prior cancer diagnosis, of whom 7.9% reported to have seen a CAM provider within the last 12 months. This did not differ significantly from neither the CHD group (6.4%, p = 0.402) nor the no cancer/CHD group (9.5%, p = 0.325). CONCLUSION: According to this study, the proportion of cancer patients seeing a CAM provider was not statistically significantly different from patients with CHD or individuals without cancer or CHD.
format Online
Article
Text
id pubmed-3305410
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33054102012-03-16 Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD Kristoffersen, Agnete E Norheim, Arne J Fønnebø, Vinjar M BMC Complement Altern Med Research Article BACKGROUND: Although use of complementary and alternative medicine (CAM) among cancer patients has been described previously, prevalence of use has not commonly been compared to other disease groups in a true population sample where CAM use or cancer is not the main focus. The aims of the present study are to (1) examine how CAM use in cancer patients differs from people with a previous CHD diagnosis and people with no cancer or CHD diagnosis in an unselected general population and (2), investigate the use of a CAM provider among individuals with a previous cancer diagnosis. METHODS: A total of 8040 men and women aged 29 to 87 in the city of Tromsø, Norway filled in a questionnaire developed specifically for the Tromsø V study with questions on life style and health issues. Visits to a CAM provider within the last 12 months and information on cancer, heart attack and angina pectoris (heart cramp) were among the questions. 1449 respondents were excluded from the analyses. RESULTS: Among the 6591 analysed respondents 331 had a prior cancer diagnosis, of whom 7.9% reported to have seen a CAM provider within the last 12 months. This did not differ significantly from neither the CHD group (6.4%, p = 0.402) nor the no cancer/CHD group (9.5%, p = 0.325). CONCLUSION: According to this study, the proportion of cancer patients seeing a CAM provider was not statistically significantly different from patients with CHD or individuals without cancer or CHD. BioMed Central 2012-01-12 /pmc/articles/PMC3305410/ /pubmed/22240073 http://dx.doi.org/10.1186/1472-6882-12-1 Text en Copyright ©2012 Kristoffersen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kristoffersen, Agnete E
Norheim, Arne J
Fønnebø, Vinjar M
Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
title Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
title_full Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
title_fullStr Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
title_full_unstemmed Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
title_short Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
title_sort any difference? use of a cam provider among cancer patients, coronary heart disease (chd) patients and individuals with no cancer/chd
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305410/
https://www.ncbi.nlm.nih.gov/pubmed/22240073
http://dx.doi.org/10.1186/1472-6882-12-1
work_keys_str_mv AT kristoffersenagnetee anydifferenceuseofacamprovideramongcancerpatientscoronaryheartdiseasechdpatientsandindividualswithnocancerchd
AT norheimarnej anydifferenceuseofacamprovideramongcancerpatientscoronaryheartdiseasechdpatientsandindividualswithnocancerchd
AT fønnebøvinjarm anydifferenceuseofacamprovideramongcancerpatientscoronaryheartdiseasechdpatientsandindividualswithnocancerchd